SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009861
Filing Date
2015-11-06
Accepted
2015-11-06 10:19:42
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-10q_20150930.htm 10-Q 1549366
2 EX-31.1 clvs-ex311_8.htm EX-31.1 15197
3 EX-31.2 clvs-ex312_7.htm EX-31.2 15068
4 EX-32.1 clvs-ex321_6.htm EX-32.1 4280
5 EX-32.2 clvs-ex322_9.htm EX-32.2 4397
  Complete submission text file 0001564590-15-009861.txt   5718041

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20150930.xml EX-101.INS 1242133
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20150930.xsd EX-101.SCH 42724
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20150930_cal.xml EX-101.CAL 44075
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20150930_def.xml EX-101.DEF 103460
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20150930_lab.xml EX-101.LAB 324982
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20150930_pre.xml EX-101.PRE 244416
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 151202841
SIC: 2834 Pharmaceutical Preparations